Effects of antipsychotics on the unborn child: what is known and how should this influence prescribing?

H B Pinkofsky1

  • 1Department of Psychiatry, Louisiana State University Medical Center, Shreveport 71130, USA. hpinko@lsumc.edu

Paediatric Drugs
|August 11, 2000
PubMed

Insights

Managing psychosis during pregnancy involves complex decisions due to potential risks. Careful assessment of benefits and risks is crucial for both medication and non-medication approaches in pregnant patients.

Area of Science:

  • Perinatal Psychiatry
  • Neuropharmacology
  • Obstetrics

Background:

  • Psychosis during pregnancy presents significant management challenges.
  • Requires multidisciplinary collaboration between family, healthcare professionals, and physicians.
  • Treatment decisions involve balancing maternal and fetal well-being against symptom severity.

Purpose of the Study:

  • To review the complexities and risks associated with managing psychosis in pregnant patients.
  • To evaluate treatment options, including medication and electroconvulsive therapy.
  • To highlight the incomplete research on antipsychotic use during pregnancy.

Main Methods:

  • Review of existing literature on psychosis treatment during pregnancy.
  • Analysis of risks associated with antipsychotic medications, including teratogenic and neonatal effects.
  • Consideration of non-pharmacological interventions like electroconvulsive therapy.

Main Results:

  • No treatment is entirely risk-free; decisions require careful risk-benefit assessment.
  • First-trimester antipsychotic use, particularly low-potency phenothiazines, may increase congenital abnormality risk.
  • Adverse effects of antipsychotics (e.g., hypotension, sedation) and newer atypical agents require consideration.

Conclusions:

  • Treatment of psychosis in pregnancy necessitates a thorough evaluation of all factors.
  • Electroconvulsive therapy may offer an alternative to antipsychotic medication.
  • Further research is needed to fully understand the safety profiles of antipsychotics in pregnancy.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...